Anti-p200 Pemphigoid Mimicking Acquired Reactive Perforating Collagenosis

Authors

  • Janik Fleißner Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
  • Katrin Ickrath Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
  • Matthias Goebeler Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
  • Sandrine Benoit Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
  • Andreas Kerstan Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany

DOI:

https://doi.org/10.2340/actadv.v104.40627

Keywords:

Anti-p200 Pemphigoid, Autoimmune blistering disease, Acquired reactive perforating collagenosis

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Chen KR, Shimizu S, Miyakawa S, Ishiko A, Shimizu H, Hashimoto T. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Br J Dermatol 1996; 134: 340-346.

https://doi.org/10.1111/j.1365-2133.1996.tb07625.x

van Beek N, Weidinger A, Schneider SW, Kleinheinz A, Glaser R, Holtsche MM, et al. Incidence of pemphigoid diseases in Northern Germany in 2016: first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases. J Eur Acad Dermatol Venereol 2021; 35: 1197-1202.

https://doi.org/10.1111/jdv.17107

Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996; 106: 465-470.

https://doi.org/10.1111/1523-1747.ep12343631

Kridin K, Ahmed AR. Anti-p200 pemphigoid: a systematic review. Front Immunol 2019; 10: 2466.

https://doi.org/10.3389/fimmu.2019.02466

Goletz S, Pigors M, Lari TR, Hammers CM, Wang Y, Emtenani S, et al. Laminin beta4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid. J Am Acad Dermatol 2024; 90: 790-797.

https://doi.org/10.1016/j.jaad.2023.11.014

Goletz S, Probst C, Komorowski L, Radzimski C, Mindorf S, Holtsche MM, et al. Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin beta4 subunit. Br J Dermatol 2024; 191: 140-141.

https://doi.org/10.1093/bjd/ljae136

Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol 2014; 71: 185-191.

https://doi.org/10.1016/j.jaad.2014.02.036

Semeria L, Lamiaux M, Quinchon JF, Modiano P. Anti-p200 pemphigoid mimicking erythema multiforme. JAAD Case Rep 2022; 21: 157-159.

https://doi.org/10.1016/j.jdcr.2022.01.011

Wagner G, Sachse MM. Acquired reactive perforating dermatosis. J Dtsch Dermatol Ges 2013; 11: 723-729, 723-730.

https://doi.org/10.1111/ddg.12131

Kakehi Y, Miyagawa F, Ogawa K, Hashimoto T, Asada H. Case of anti-laminin gamma1 pemphigoid associated with ulcerative colitis and acquired perforating dermatosis. J Dermatol 2021; 48: e35-e36.

https://doi.org/10.1111/1346-8138.15624

Maki N, Nishie W, Takazawa M, Kakurai M, Yamada T, Umemoto N, et al. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis. J Dermatol 2018; 45: 600-602.

https://doi.org/10.1111/1346-8138.14254

Nomura H, Mukai M, Niimi Y, Egami S, Yokoyama T, Sugiura M, et al. Coexistence of acquired perforating dermatosis and bullous pemphigoid: three cases. Eur J Dermatol 2017; 27: 192-193.

https://doi.org/10.1684/ejd.2016.2944

Schauer F, Kern JS, Virtic O, Technau-Hafsi K, Meiss F, Thoma K, et al. A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid. Br J Dermatol 2019; 180: 231-232.

https://doi.org/10.1111/bjd.17146

Tani S, Ishii N, Hashimoto T, Tsujioka K. Bullous pemphigoid arising in a patient with acquired perforating dermatosis. Clin Exp Dermatol 2017; 42: 406-409.

https://doi.org/10.1111/ced.13080

Tasanen K, Varpuluoma O, Nishie W. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. Front Immunol 2019; 10: 1238.

https://doi.org/10.3389/fimmu.2019.01238

Published

2024-09-09

How to Cite

Fleißner, J., Ickrath, K., Goebeler, M., Benoit, S., & Kerstan, A. (2024). Anti-p200 Pemphigoid Mimicking Acquired Reactive Perforating Collagenosis. Acta Dermato-Venereologica, 104, adv40627. https://doi.org/10.2340/actadv.v104.40627